The private capital firm that turned Markerstudy into a personal lines heavyweight could soon have a new owner of its own.

Pollen Street said on Wednesday that its board is reviewing its strategic options, and that going private is one of them. It has also started preliminary talks with a small number of third parties about whether they might make an offer. The company stressed that discussions are at "a very early stage" and that no bid is guaranteed. The statement followed a Reuters report that the firm had hired an adviser. Ardea Partners is acting for Pollen Street.

The shares rose 16.6% to 950p by mid-morning, their highest level since January. At that price the FTSE 250 group is worth about £560m, up from around £490m before the first reports emerged. Eight days earlier, the stock had fallen 5% to 785p on half-year results. Those results showed assets under management up 39% to £8.5bn, but pre-tax profit down 31% to £20.3m.

The company hasn't said who it is talking to. The Takeover Panel has excused it from naming suitors unless they surface in market speculation. According to Reuters, the interested parties include mid-sized private equity firms and Wafra, which bought a minority stake in 2020 through its Capital Constellation platform. Wafra declined to comment.

Any buyer will also have to deal with Lindsey McMurray. She founded Pollen Street in 2013 after leaving RBS, still runs it, and owns roughly a fifth of the shares.

Read next: Markerstudy hit with FCA restrictions

For brokers, the name that matters is Markerstudy. Pollen Street led a £200m investment in the Sevenoaks group in January 2021, and a string of acquisitions followed. The largest was the £1.2bn merger with Atlanta, owner of Swinton, approved by the regulator in 2024. It left the group writing about £3bn of gross written premium, with Ardonagh holding 23%. The group's retail brands now include Swinton, Carole Nash, Marmalade, Budget and Purely Pets.

All that dealmaking caught the regulator's attention. In February, the Financial Conduct Authority capped customer numbers and required agreed capital levels across more than a dozen Markerstudy businesses, using voluntary requirements rather than formal enforcement. Markerstudy said it had agreed the cap with the FCA. Its 2024 accounts showed revenue of £694m and a post-tax loss of £141.7m. Interest of £136m on nearly £1.4bn of debt accounted for most of that loss.

The group has spent 2026 reorganising. It set up a commercial division aiming for £200m of GWP, split out a dedicated retail broking arm, and in July sold its MGA, Markerstudy Insurance Services, to Saturn Holdings. Saturn owns Tradex and Soteria and is also a Pollen Street portfolio company, so the deal moved a business from one Pollen Street company to another.

Read next: Saturn takes Markerstudy services arm in-house after two-year partnership

Wednesday's statement didn't mention the portfolio, and nothing suggests Markerstudy or Saturn is on the block. But a change of control at the top could change how, and how soon, the firm wants to cash in on investments.

A Markerstudy flotation is the most obvious example. Last November, Pollen Street was reported to have held early talks with banks about a London listing that could value the insurer at more than £3bn. Since then, a person close to Markerstudy has said there are no plans to float.

Pollen Street in its current form dates from 2022, when Honeycomb Investment Trust combined with Pollen Street Capital, the manager that had run it for years. Outside insurance, it backs challenger bank Shawbrook, which it floated with BC Partners last October, and Dutch digital lender bunq. It still expects to reach its £10bn assets under management target with its next round of flagship funds.

Read next: Markerstudy reportedly preparing for London IPO amid sector shake-up

Pollen Street's move fits a wider trend. Mid-sized managers are being squeezed as they compete for investor money and absorb rising regulatory and running costs. In February, Nuveen agreed a £9.9bn cash takeover of Schroders. Nuveen is owned by the US insurer and pension provider TIAA, and the deal is due to complete by the end of the year. Insurers are consolidating too: Zurich's £8.1bn deal for Beazley has just cleared the High Court.

Read next: Zurich's £8.1bn swoop for Beazley gets the green light from London's High Court

Pollen Street said it would update the market in due course. Once a suitor is publicly named, the Takeover Code usually gives it 28 days to make a firm offer or walk away.